CDW Quote, Financials, Valuation and Earnings

Intellinetics has a net margin of 4.33% compared to CDW's net margin of -17.13%. CDW's return on equity of 47.92% beat Intellinetics's return on equity of -10.61%.

CDW has a consensus price target of $208.83, signalling upside risk potential of 22.54%. On the other hand Intellinetics has an analysts' consensus of $16.50 which suggests that it could grow by 42.24%. Given that Intellinetics has higher upside potential than CDW, analysts believe Intellinetics is more attractive than CDW.

CDW has a beta of 0.949, which suggesting that the stock is 5.065% less volatile than S&P 500. In comparison Intellinetics has a beta of 0.525, suggesting its less volatile than the S&P 500 by 47.506%.

CDW has a quarterly dividend of $0.63 per share corresponding to a yield of 1.46%. Intellinetics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CDW pays 30.81% of its earnings as a dividend. Intellinetics pays out -- of its earnings as a dividend. CDW's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

CDW quarterly revenues are $5.2B, which are larger than Intellinetics quarterly revenues of $4.2M. CDW's net income of $224.9M is higher than Intellinetics's net income of -$727.6K. Notably, CDW's price-to-earnings ratio is 21.12x while Intellinetics's PE ratio is 248.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CDW is 1.08x versus 2.85x for Intellinetics. Usually stocks with elevated PS ratios are considered overvalued.

Parsons has a net margin of 4.33% compared to CDW's net margin of 4.26%. CDW's return on equity of 47.92% beat Parsons's return on equity of 16.94%.

CDW has a consensus price target of $208.83, signalling upside risk potential of 22.54%. On the other hand Parsons has an analysts' consensus of $80.12 which suggests that it could grow by 14.88%. Given that CDW has higher upside potential than Parsons, analysts believe CDW is more attractive than Parsons.

CDW has a beta of 0.949, which suggesting that the stock is 5.065% less volatile than S&P 500. In comparison Parsons has a beta of 0.527, suggesting its less volatile than the S&P 500 by 47.29%.

CDW has a quarterly dividend of $0.63 per share corresponding to a yield of 1.46%. Parsons offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CDW pays 30.81% of its earnings as a dividend. Parsons pays out -- of its earnings as a dividend. CDW's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

CDW quarterly revenues are $5.2B, which are larger than Parsons quarterly revenues of $1.6B. CDW's net income of $224.9M is higher than Parsons's net income of $66.2M. Notably, CDW's price-to-earnings ratio is 21.12x while Parsons's PE ratio is 29.43x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CDW is 1.08x versus 1.18x for Parsons. Usually stocks with elevated PS ratios are considered overvalued.

Science Applications International has a net margin of 4.33% compared to CDW's net margin of 3.62%. CDW's return on equity of 47.92% beat Science Applications International's return on equity of 21.85%.

CDW has a consensus price target of $208.83, signalling upside risk potential of 22.54%. On the other hand Science Applications International has an analysts' consensus of $121.92 which suggests that it could grow by 15.64%. Given that CDW has higher upside potential than Science Applications International, analysts believe CDW is more attractive than Science Applications International.

CDW has a beta of 0.949, which suggesting that the stock is 5.065% less volatile than S&P 500. In comparison Science Applications International has a beta of 0.503, suggesting its less volatile than the S&P 500 by 49.748%.

CDW has a quarterly dividend of $0.63 per share corresponding to a yield of 1.46%. Science Applications International offers a yield of 1.4% to investors and pays a quarterly dividend of $0.37 per share. CDW pays 30.81% of its earnings as a dividend. Science Applications International pays out 20.72% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

CDW quarterly revenues are $5.2B, which are larger than Science Applications International quarterly revenues of $1.9B. CDW's net income of $224.9M is higher than Science Applications International's net income of $68M. Notably, CDW's price-to-earnings ratio is 21.12x while Science Applications International's PE ratio is 14.79x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CDW is 1.08x versus 0.69x for Science Applications International. Usually stocks with elevated PS ratios are considered overvalued.

WidePoint has a net margin of 4.33% compared to CDW's net margin of -2.12%. CDW's return on equity of 47.92% beat WidePoint's return on equity of -14.61%.

CDW has a consensus price target of $208.83, signalling upside risk potential of 22.54%. On the other hand WidePoint has an analysts' consensus of $7.50 which suggests that it could grow by 148.34%. Given that WidePoint has higher upside potential than CDW, analysts believe WidePoint is more attractive than CDW.

CDW has a beta of 0.949, which suggesting that the stock is 5.065% less volatile than S&P 500. In comparison WidePoint has a beta of 1.593, suggesting its more volatile than the S&P 500 by 59.32%.

CDW has a quarterly dividend of $0.63 per share corresponding to a yield of 1.46%. WidePoint offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CDW pays 30.81% of its earnings as a dividend. WidePoint pays out -- of its earnings as a dividend. CDW's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

CDW quarterly revenues are $5.2B, which are larger than WidePoint quarterly revenues of $34.2M. CDW's net income of $224.9M is higher than WidePoint's net income of -$724.1K. Notably, CDW's price-to-earnings ratio is 21.12x while WidePoint's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CDW is 1.08x versus 0.20x for WidePoint. Usually stocks with elevated PS ratios are considered overvalued.